Anticholinergic Effects of Trazodone and Amitriptyline

Mechanism and Clinical Implications

The American Academy of Family Physicians notes that amitriptyline is a tertiary-amine tricyclic antidepressant with high affinity for muscarinic receptors, causing pronounced anticholinergic effects including dry mouth, constipation, urinary retention, blurred vision, and confusion 1, 2, 3
The American Geriatric Society's Beers Criteria specifically identifies tertiary-amine tricyclics like amitriptyline as potentially inappropriate medications due to significant anticholinergic effects, while trazodone is better tolerated in elderly patients 1, 2

Patients with dementia are at extremely high risk from anticholinergic medications; trazodone's minimal anticholinergic activity makes it theoretically safer, though it carries other risks including orthostatic hypotension and cardiac arrhythmias 4
Patients with urinary retention, constipation, cognitive impairment, or narrow-angle glaucoma should avoid amitriptyline's strong anticholinergic effects 1, 3

With amitriptyline, expect anticholinergic side effects such as drowsiness, weight gain, dry mouth, constipation, urinary retention, blurred vision, confusion, and cognitive impairment 1, 3, 5
The American Academy of Sleep Medicine recommends choosing trazodone over amitriptyline for depression or insomnia when anticholinergic effects must be minimized, and monitoring for orthostatic hypotension, sedation, dizziness, and priapism 1, 4, 6

In adults receiving amitriptyline 50–100 mg daily for tension‑type headache prophylaxis, clinicians should monitor for anticholinergic adverse effects, with particular vigilance in older patients and those with multiple cardiac comorbidities. 7

Cyclobenzaprine, a muscle relaxant structurally related to amitriptyline, possesses comparable anticholinergic activity and should be discontinued on the day of surgery to avoid interactions with anesthetic agents. 8